These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 17826340)

  • 1. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
    Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
    Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
    Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
    Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
    Gass J; Cannon A; Mackenzie IR; Boeve B; Baker M; Adamson J; Crook R; Melquist S; Kuntz K; Petersen R; Josephs K; Pickering-Brown SM; Graff-Radford N; Uitti R; Dickson D; Wszolek Z; Gonzalez J; Beach TG; Bigio E; Johnson N; Weintraub S; Mesulam M; White CL; Woodruff B; Caselli R; Hsiung GY; Feldman H; Knopman D; Hutton M; Rademakers R
    Hum Mol Genet; 2006 Oct; 15(20):2988-3001. PubMed ID: 16950801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
    Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
    Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.
    Yu CE; Bird TD; Bekris LM; Montine TJ; Leverenz JB; Steinbart E; Galloway NM; Feldman H; Woltjer R; Miller CA; Wood EM; Grossman M; McCluskey L; Clark CM; Neumann M; Danek A; Galasko DR; Arnold SE; Chen-Plotkin A; Karydas A; Miller BL; Trojanowski JQ; Lee VM; Schellenberg GD; Van Deerlin VM
    Arch Neurol; 2010 Feb; 67(2):161-70. PubMed ID: 20142524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
    Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
    Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.
    Rademakers R; Eriksen JL; Baker M; Robinson T; Ahmed Z; Lincoln SJ; Finch N; Rutherford NJ; Crook RJ; Josephs KA; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Caselli RJ; Wszolek ZK; Uitti RJ; Feldman H; Hutton ML; Mackenzie IR; Graff-Radford NR; Dickson DW
    Hum Mol Genet; 2008 Dec; 17(23):3631-42. PubMed ID: 18723524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
    Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
    J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg.
    Redaelli V; Rossi G; Maderna E; Kovacs GG; Piccoli E; Caroppo P; Cacciatore F; Spinello S; Grisoli M; Sozzi G; Salmaggi A; Tagliavini F; Giaccone G
    Brain Pathol; 2018 Jan; 28(1):72-76. PubMed ID: 27997711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
    Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
    PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Martinez-Lage M; Sleiman PM; Hu W; Greene R; Wood EM; Bing S; Grossman M; Schellenberg GD; Hatanpaa KJ; Weiner MF; White CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach TG; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Pickering-Brown SM; Snowden J; van Swieten JC; Heutink P; Seelaar H; Murrell JR; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio E; Lladó A; Miller BL; Alzualde A; Moreno F; Rohrer JD; Mackenzie IR; Feldman HH; Hamilton RL; Cruts M; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bird TD; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van Deerlin VM
    Arch Neurol; 2011 Apr; 68(4):488-97. PubMed ID: 21482928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes.
    Short RA; Graff-Radford NR; Adamson J; Baker M; Hutton M
    Arch Neurol; 2002 Apr; 59(4):611-5. PubMed ID: 11939896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation.
    Bruni AC; Momeni P; Bernardi L; Tomaino C; Frangipane F; Elder J; Kawarai T; Sato C; Pradella S; Wakutani Y; Anfossi M; Gallo M; Geracitano S; Costanzo A; Smirne N; Curcio SA; Mirabelli M; Puccio G; Colao R; Maletta RG; Kertesz A; St George-Hyslop P; Hardy J; Rogaeva E
    Neurology; 2007 Jul; 69(2):140-7. PubMed ID: 17620546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
    Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; López de Munain A; Zulaica M; Moreno F; Le Ber I; Pasquier F; Hannequin D; Sánchez-Valle R; Antonell A; Lladó A; Parsons TM; Finch NA; Finger EC; Lippa CF; Huey ED; Neumann M; Heutink P; Synofzik M; Wilke C; Rissman RA; Slawek J; Sitek E; Johannsen P; Nielsen JE; Ren Y; van Blitterswijk M; DeJesus-Hernandez M; Christopher E; Murray ME; Bieniek KF; Evers BM; Ferrari C; Rollinson S; Richardson A; Scarpini E; Fumagalli GG; Padovani A; Hardy J; Momeni P; Ferrari R; Frangipane F; Maletta R; Anfossi M; Gallo M; Petrucelli L; Suh E; Lopez OL; Wong TH; van Rooij JGJ; Seelaar H; Mead S; Caselli RJ; Reiman EM; Noel Sabbagh M; Kjolby M; Nykjaer A; Karydas AM; Boxer AL; Grinberg LT; Grafman J; Spina S; Oblak A; Mesulam MM; Weintraub S; Geula C; Hodges JR; Piguet O; Brooks WS; Irwin DJ; Trojanowski JQ; Lee EB; Josephs KA; Parisi JE; Ertekin-Taner N; Knopman DS; Nacmias B; Piaceri I; Bagnoli S; Sorbi S; Gearing M; Glass J; Beach TG; Black SE; Masellis M; Rogaeva E; Vonsattel JP; Honig LS; Kofler J; Bruni AC; Snowden J; Mann D; Pickering-Brown S; Diehl-Schmid J; Winkelmann J; Galimberti D; Graff C; Öijerstedt L; Troakes C; Al-Sarraj S; Cruchaga C; Cairns NJ; Rohrer JD; Halliday GM; Kwok JB; van Swieten JC; White CL; Ghetti B; Murell JR; Mackenzie IRA; Hsiung GR; Borroni B; Rossi G; Tagliavini F; Wszolek ZK; Petersen RC; Bigio EH; Grossman M; Van Deerlin VM; Seeley WW; Miller BL; Graff-Radford NR; Boeve BF; Dickson DW; Biernacka JM; Rademakers R
    Lancet Neurol; 2018 Jun; 17(6):548-558. PubMed ID: 29724592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA; Cairns NJ
    Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.